Jonatan Chimal-Barrera

Ignacio Chavez, DIF, Mexico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

SMOC2 promotes partial epithelial-to-mesenchymal transition and maladaptive repair in renal tubular epithelial cells.

SMOC2 promotes partial epithelial-to-mesenchymal transition and maladaptive repair in renal tubular epithelial cells.

Journal: JCI insight

Published: August 12, 2026

Matrix Gla Protein is a novel regulator of TGFβ-dependent fibroblast activation and kidney fibrosis.

Matrix Gla Protein is a novel regulator of TGFβ-dependent fibroblast activation and kidney fibrosis.

Journal: Molecular biomedicine

Published: February 12, 2026

Reprogramming the tumor microenvironment: methylmalonic acid at the intersection of ccRCC metabolism and macrophage polarization.

Reprogramming the tumor microenvironment: methylmalonic acid at the intersection of ccRCC metabolism and macrophage polarization.

Journal: Cell death and differentiation

Published: November 17, 2025

Antagonism of Kinin Receptors B1 and B2 Attenuates Folic Acid-Induced Tubulointerstitial Fibrosis in Mice.

Antagonism of Kinin Receptors B1 and B2 Attenuates Folic Acid-Induced Tubulointerstitial Fibrosis in Mice.

Journal: Basic & clinical pharmacology & toxicology

Published: August 20, 2025

Matricellular protein SMOC2 safeguards tubular integrity in acute kidney injury via integrin β3-dependent inhibition of CCND1-CDK4/6 axis.

Matricellular protein SMOC2 safeguards tubular integrity in acute kidney injury via integrin β3-dependent inhibition of CCND1-CDK4/6 axis.

Journal: Molecular biomedicine

Published: August 04, 2025

Aldosterone synthase inhibition: a novel bullet to fight cardiovascular-kidney-metabolic syndrome.

Aldosterone synthase inhibition: a novel bullet to fight cardiovascular-kidney-metabolic syndrome.

Journal: Journal of molecular endocrinology

Published: April 09, 2025

Inhibition of MCL-1 to eliminate senescent cells and mitigate renal fibrosis in aristolochic acid nephropathy.

Inhibition of MCL-1 to eliminate senescent cells and mitigate renal fibrosis in aristolochic acid nephropathy.

Journal: Cell death & disease

Published: February 27, 2025

Mineralocorticoid receptor antagonism for non-diabetic kidney disease.

Mineralocorticoid receptor antagonism for non-diabetic kidney disease.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: April 05, 2024

FLT4 activation promotes acute lymphoid leukemia survival through stabilization of MDM2/MDMX and inactivation of p53.

FLT4 activation promotes acute lymphoid leukemia survival through stabilization of MDM2/MDMX and inactivation of p53.

Journal: Oncogenesis

Published: March 11, 2024

Kinin B1 Receptor Antagonism Prevents Acute Kidney Injury to Chronic Kidney Disease Transition in Renal Ischemia-Reperfusion by Increasing the M2 Macrophages Population in C57BL6J Mice.

Kinin B1 Receptor Antagonism Prevents Acute Kidney Injury to Chronic Kidney Disease Transition in Renal Ischemia-Reperfusion by Increasing the M2 Macrophages Population in C57BL6J Mice.

Journal: Biomedicines

Published: June 15, 2023

Mineralocorticoid receptor antagonists: A new therapeutic option for diabetic kidney disease

Mineralocorticoid receptor antagonists: A new therapeutic option for diabetic kidney disease

Journal: Medecine sciences : M/S

Published: April 24, 2023

Tungsten toxicity on kidney tubular epithelial cells induces renal inflammation and M1-macrophage polarization.

Tungsten toxicity on kidney tubular epithelial cells induces renal inflammation and M1-macrophage polarization.

Journal: Cell biology and toxicology

Published: February 27, 2023

Showing 1-12 of 61

Last Updated: 09/26/2026